Revision as of 05:28, 5 February 2009 editPlumpurple (talk | contribs)3,347 editsNo edit summary← Previous edit | Revision as of 03:51, 6 February 2009 edit undoSmackBot (talk | contribs)3,734,324 editsm Date maintenance tags and general fixesNext edit → | ||
Line 25: | Line 25: | ||
| routes_of_administration = | | routes_of_administration = | ||
}} | }} | ||
{{Unreferenced|date=February 2009}} | |||
{{unsourced}} | |||
'''Rociverine''' is an ]. | '''Rociverine''' is an ]. | ||
⚫ | {{Drugs for functional gastrointestinal disorders}} | ||
⚫ | {{pharmacology-stub}} | ||
⚫ | {{pharmacology-stub}} | ||
⚫ | {{Drugs for functional gastrointestinal disorders}} |
Revision as of 03:51, 6 February 2009
Pharmaceutical compoundClinical data | |
---|---|
Other names | (1S)-1-(diethylamino)propan-2-yl 1-hydroxybi(cyclohexane)-2-carboxylate |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.053.356 |
Chemical and physical data | |
Formula | C20H37NO3 |
Molar mass | 339.51 g/mol g·mol |
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Rociverine" – news · newspapers · books · scholar · JSTOR (February 2009) (Learn how and when to remove this message) |
Rociverine is an antimuscarinic.
Drugs for functional gastrointestinal disorders (A03) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drugs for functional bowel disorders |
| ||||||||||||
Belladonna and derivatives (antimuscarinics) |
| ||||||||||||
Propulsives |
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |